Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Keita P. Mori"'
Autor:
Akie Ikushima, Takuya Ishimura, Keita P. Mori, Hiroyuki Yamada, Sayaka Sugioka, Akira Ishii, Naohiro Toda, Shoko Ohno, Yukiko Kato, Takaya Handa, Motoko Yanagita, Hideki Yokoi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract One of the most common causes of peritoneal dialysis withdrawal is ultrafiltration failure which is characterized by peritoneal membrane thickening and fibrosis. Although previous studies have demonstrated the inhibitory effect of p38 MAPK i
Externí odkaz:
https://doaj.org/article/ee4f9235bcb34ba88efba556ea452fdc
Autor:
Takaya Handa, Keita P. Mori, Akira Ishii, Shoko Ohno, Yugo Kanai, Haruko Watanabe-Takano, Akihiro Yasoda, Takashige Kuwabara, Nobuyuki Takahashi, Naoki Mochizuki, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Natriuretic peptides exert multiple effects by binding to natriuretic peptide receptors (NPRs). Osteocrin (OSTN) binds with high affinity to NPR-C, a clearance receptor for natriuretic peptides, and inhibits degradation of natriuretic peptid
Externí odkaz:
https://doaj.org/article/ee6ea24a24204f86924bd4ac7c5ffbb8
Autor:
Hiroyuki Arai, Keita P. Mori, Hideki Yokoi, Ken Mizuta, Jumpei Ogura, Ko Suginami, Tomomi Endo, Yoshihiro Ikeda, Takeshi Matsubara, Tatsuo Tsukamoto, Motoko Yanagita
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-11 (2020)
Abstract Background Pregnancy in dialysis patients is rare but challenging both for nephrologists and obstetricians. Although intensified hemodialysis is effective to achieve favorable clinical outcomes in this clinical setting, the evidence concerni
Externí odkaz:
https://doaj.org/article/675642bb15b54eca8e5a1d0ff06d9422
Autor:
Erina Ono, Eiichiro Uchino, Keita P. Mori, Hideki Yokoi, Naohiro Toda, Kenichi Koga, Masato Kasahara, Takeshi Matsubara, Motoko Yanagita
Publikováno v:
Renal Replacement Therapy, Vol 4, Iss 1, Pp 1-10 (2018)
Abstract Background Peritoneal dialysis (PD)-associated peritonitis caused by nontuberculous mycobacteria (NTM), including Mycobacterium abscessus (M. abscessus), is a rare but serious complication that forces PD to be withdrawn. Several cases of per
Externí odkaz:
https://doaj.org/article/61b8e8f227654b5fb29b441272be087d
Autor:
Noriaki Sato, Keita P Mori, Kaoru Sakai, Hitomi Miyata, Shinya Yamamoto, Takashi Kobayashi, Hironori Haga, Motoko Yanagita, Yasushi Okuno
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0282534 (2023)
BK polyomavirus-associated nephropathy occurs in kidney transplant recipients under immunosuppressive treatment. BK polyomavirus is implicated in cancer development and invasion, and case reports of renal cell carcinoma and urothelial carcinoma possi
Externí odkaz:
https://doaj.org/article/a1a3783414834d83b4beaab08454ff7d
Autor:
Haruomi Nishio, Akira Ishii, Hiroyuki Yamada, Keita P Mori, Yukiko Kato, Shoko Ohno, Takaya Handa, Sayaka Sugioka, Takuya Ishimura, Akie Ikushima, Yui Inoue, Naoto Minamino, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi
Publikováno v:
Nephrology Dialysis Transplantation.
Background Aldosterone has been assumed to be one of aggravating factors in diabetic kidney disease (DKD). Natriuretic peptides/guanylyl cyclase-A/cGMP signalling has been shown to ameliorate aldosterone-induced renal injury in mice. Sacubitril/valsa
Autor:
Noriaki Sato, Atsuko Shiraki, Keita P. Mori, Kaoru Sakai, Long Tan, Yoshinori Takemura, Yasushi Okuno, Kazunari Tanabe, Kimiyasu Shiraki
Publikováno v:
Antiviral research. 208
BK polyomavirus-associated nephropathy is one of serious complications in transplant recipients. Everolimus-a mammalian target of rapamycin inhibitor-has been shown to reduce the incidence of BK polyomavirus infection in transplant recipients. In thi
Autor:
Sayaka Sugioka, Hiroyuki Yamada, Akira Ishii, Yukiko Kato, Keita P Mori, Shoko Ohno, Takaya Handa, Akie Ikushima, Takuya Ishimura, Takeshi Tokudome, Taiji Matsusaka, Angel R Nebreda, Motoko Yanagita, Hideki Yokoi
Publikováno v:
Journal of Hypertension. 41:e277
Autor:
Shoko Ohno, Naoki Mochizuki, Haruko Watanabe-Takano, Yugo Kanai, Takashige Kuwabara, Motoko Yanagita, Akira Ishii, Nobuyuki Takahashi, Takaya Handa, Akihiro Yasoda, Masashi Mukoyama, Keita P. Mori, Hideki Yokoi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Natriuretic peptides exert multiple effects by binding to natriuretic peptide receptors (NPRs). Osteocrin (OSTN) binds with high affinity to NPR-C, a clearance receptor for natriuretic peptides, and inhibits degradation of natriuretic peptides and co
Autor:
Yoshihiko Nishiguchi, Haruko Watanabe-Takano, Shuro Umemoto, Yusuke Hata, Daisuke Fujimoto, Tomoko Kanki, Naoki Mochizuki, Akihiro Yasoda, Ryosuke Date, Yugo Kanai, Takashige Kuwabara, Yutaka Kakizoe, Masashi Mukoyama, Keita P. Mori, Takaya Handa, Yuichiro Izumi, Hideki Yokoi
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 37(3)
Background Osteocrin (OSTN), a bone-derived humoral factor, was reported to act on heart and bone by potentiating the natriuretic peptide (NP) system. Ostn gene polymorphisms have been associated with renal function decline, but its pathophysiologica